FindTrial
Sign In

Blood and tissue samples

OTHER3 trials

Sponsors

Wake Forest University Health Sciences, Flatiron Health, University Hospital, Toulouse

Conditions

Cardiac SurgeryEsophageal CancerExtracorporeal CirculationGastric and Gastroesophageal Junction (GEJ) AdenocarcinomaLung Cancer, Nonsmall CellMelanoma (Skin Cancer)Mix of Solid Tumors (MOST)Muscle Invasive Bladder Urothelial Carcinoma

Unknown Phase

Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
Active, not recruitingNCT05415358
Wake Forest University Health SciencesLung Cancer, Nonsmall Cell
Start: 2023-01-17End: 2035-09-01Target: 23Updated: 2026-02-03
Pan-tumor MRD Study
RecruitingNCT06605404
Flatiron HealthEsophageal Cancer, Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma, Melanoma (Skin Cancer) +4
Start: 2025-01-08End: 2032-04-30Target: 1350Updated: 2025-08-14
Impact of VARIation of OXYdo-reduction Potential in Cardiac Surgery on Post-operative Outcome
Not yet recruitingNCT06840327
University Hospital, ToulouseCardiac Surgery, Extracorporeal Circulation
Start: 2025-03-31End: 2027-06-30Target: 120Updated: 2025-02-21

Related Papers

Molecular residual disease (MRD) in solid tumors.
Journal of Clinical Oncology2025-05-28